Interventions for alopecia areata

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Delamere, Finola M ^a   Sladden, M M ^b   Dobbins, H M ^b   Leonardi Bee, J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALEFACEPT; AMINOLEVULINIC ACID; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BIMATOPROST; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DESOXIMETASONE; DIPHENCYPRONE; DITHRANOL; IMIPRAMINE; LATANOPROST; LYMPHOBLAST INTERFERON; METHISOPRINOL; MINOXIDIL; PLACEBO; PREDNISOLONE; PSORALEN; SQUARIC ACID DIBUTYL ESTER; TACROLIMUS;

ACNE; ALOPECIA AREATA; ANKLE EDEMA; APPLICATION SITE IRRITATION; AROMATHERAPY; BURNING SENSATION; CLINICAL TRIAL; COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; CRYOTHERAPY; DEPRESSION; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DRY SKIN; EMBASE; EROSION; ERYTHEMA; EYELID DISEASE; FLU LIKE SYNDROME; FOLLICULITIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAIR GROWTH; HUMAN; HYPERKERATOSIS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KERATOSIS; LONG TERM CARE; MEDLINE; MOON FACE; MYALGIA; NAUSEA; OLIGOMENORRHEA; OUTCOME ASSESSMENT; PATIENT SELECTION; PRURITUS; PUSTULE; PUVA; QUALITY OF LIFE; RANDOMIZATION; REVIEW; SELF EVALUATION; SHORT COURSE THERAPY; SIDE EFFECT; SOCIAL PSYCHOLOGY; WEAKNESS; WEIGHT GAIN;

EID: 44949122790     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004413.pub2     Document Type: Review

References (65)

1. Bissonnette 2000 {published data only} Bissonnette R, Shapiro J, Zeng H, McLean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. British Journal of Dermatology 2000;143(5):1032- 5.
2. Charuwichitratana {published data only} Charuwichitratana S WPTS. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Archives of Dermatology 2000 Oct;136(10):1276-7.
3. Galbraith 1987 {published data only} Galbraith GM, Thiers BH, Jensen J, Hoehler F. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. Journal of the American Academy of Dermatology 1987;16(5 Pt 1):977-83.
4. Kar 2005 {published data only} Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. Journal of the American Academy of Dermatology 2005;52(2):287-90.
5. Khoury 1992 {published data only} *Khoury EL, Price VH, Abdel-Salam MM, Stern M, Greenspan JS. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. Journal of Investigative Dermatology 1992;99(1):40-7.
6. Khoury EL, Price VH, Abdel-Salim MM, Stern M, Greenspan JSD. Topical minoxidil in alopecia areata: immunopathologic studies. Abstract. Journal of Investigative Dermatology 1988;90(4):575.
7. Mancuso 2003 {published data only} Mancuso G, Balducci A, Casadio C, Farina P, Staffa M, Valenti L, et al.Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial. International Journal of Dermatology 2003;42(7):572-5.
8. Nelson 1994 {published data only} Nelson BR, Ratner D, Weiner ND, Egbaria K, Hamilton TA, Johnson TM, et al.Efficacy of topical cyclosporin A in the treatment of alopecia areata. Journal of Dermatological Treatment 1994;5(2):77-9.
9. Perini 1994 {published data only} Perini G, Zara M, Cipriani R, Carraro C, Preti A. Imipramine in alopecia areata. A double-blind, placebo-controlled study. Psychotherapy & Psychosomatics 1994;61(3-4):195-8.
10. Pipoli 1995 {published data only} Pipoli M, D'Argento V, Coviello C, Dell'Osso A, Mastrolanardo M, Vena GA. Evaluation of topical immunotherapy with squaric acid dibutylester, systemic interferon alpha and the combination of both in the treatment of chronic severe alopecia areata. Journal of Dermatological Treatment 1995;6(2):95-8.
11. Price 1987a {published data only} Price VH. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. Journal of the American Academy of Dermatology 1987;16(3 Pt 2):730-6.
12. Price 1987b {published data only} Price VH. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. Journal of the American Academy of Dermatology 1987;16(3 Pt 2):737-44.
13. Rongioletti 1992 {published data only} Rongioletti F, Guarrera M, Tosti A, Guerra L, Pigatto P. Topical cyclosporin A fails to improve alopecia areata - A double blind study. Journal of Dermatological Treatment 1992;3(1):13-4.
14. Ross 2005 {published data only} Ross EK, Bolduc C, Lui H, Shapiro J. Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata [9]. Journal of the American Academy of Dermatology 2005;53(6):1095-6.
15. Shapiro 1993 {published data only} *Shapiro J, Tan J, Ho V, Abbott F, Tron V. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. Journal of the American Academy of Dermatology 1993;29(5 Pt 1):729-35.
16. Shapiro J, Tan J, Ho V, Tron V. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. Journal of Investigative Dermatology 1995;104(Suppl:) :36S.
17. Shapiro J, Tan J, Tron V. Diphencyprone and minoxidil in alopecia areata: a clinical and immunopathologic evaluation. Abstract 66. Journal of Investigative Dermatology 1992;98(4):562.
18. Tosti 1991 {published data only} Tosti A, Bardazzi F, Guerra L. Alopecia totalis: is treating nonresponder patients useful?. Journal of the American Academy of Dermatology 1991;24(3):455-6.
19. Tosti 2005 {published data only} Tosti A, Iorizzo M, Milani M. Efficacy and safety of a new clobetasol propionate 0.05% foam in Alopecia areata: A randomised, double-blind placebo controlled trial. Abstract P08.17. Journal of the European Academy of Dermatology and Venereology 2005;19(Suppl 2):222-3.
20. White 1985 {published data only} White SI, Friedmann PS. Topical minoxidil lacks efficacy in alopecia areata [letter]. Archives of Dermatology 1985;121(5):591.
21. Berth-Jones 1991 Berth-Jones J, Hutchinson PE. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clinical & Experimental Dermatology 1991;16(3):172-5.
22. Olsen 1992 Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Archives of Dermatology 1992;128(11):1467-73.
23. Price 1987c Price VH. Topical minoxidil in extensive alopecia areata, including 3-year follow-up. Dermatologica 1987c;175(Suppl 2):36-41.
24. Price 1999 Price, VH. Trancik, R. Rundegren, J. Topical Minoxidil 5% in the treatment of Alopecia Areata. The 3rd International Research Workshop on Alopecia Areata and 2nd Intercontinental Meeting of Hair Research Societies Journal of Investigative Dermatology Symposium Proceedings. 1999; Vol. 4, issue 3:252.
25. Tosti 1986 Tosti A, De Padova MP, Minghetti G, Veronesi S. Therapies versus placebo in the treatment of patchy alopecia areata. Journal of the American Academy of Dermatology 1986;15(2 Pt 1):209-10.
26. Duvic 2004 Duvic M. Phase II randomized bilateral comparison of bexarotene 1 % topical gel in alopecia areata. Journal of Investigative Dermatology 2004;122(3):A47.
27. Fenton 1983 *Fenton DA. Topical minoxidil in the treatment of alopecia areata. British Medical Journal Clinical Research Ed 1983 Oct 8;287(6398):1015-7.
28. Fenton D A. A controlled trial of topical minoxidil in the treatment of alopecia areata. Abstract. British Journal of Dermatology 1983;109(Suppl 24):36-7.
29. Lee 1986 Lee MG, Yoon MS, Lee JB, et al.A clinical study of topical minoxidil therapy in alopecia. Multicenter trials. Korean Journal of Dermatology 1986;24(2):181-9.
30. Maia 2003 Maia CPA, Fernandes NC. Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças / Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children Portuguese. Anais Brasileiros De Dermatologia 2003;78(1):63-71.
31. Ochoa 1993 Ochoa J, Saúl A, Arellano Mendoza I. Aspectos clínicos de la alopecia areata: tratamiento tópico comparativo entre antralina y betametasona / Clinical aspects of the alopesia areata: comparative topical treatment between anthralin and betamethasane. Dermatologia Revista Mexicana 1993;37(6):476-81.
32. Pigatto 1987 Pigatto PD RRPMAG. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo]. [Italian]. Giornale Italiano Di Dermatologia e Venereologia 1987 Dec;122 (12):667-70.
33. Shi 1986 Shi YP. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia [letter]. Archives of Dermatology 1986;122(5):506.
34. Swanson 1981 Swanson NA, Mitchell AJ, Leahy MS, Headington JT, Diaz LA. Topical treatment of alopecia areata. Archives of Dermatology 1981;117(7):384-7.
35. Vali 2005 Vali A. Evaluation of the efficacy of onion juice in treatment of alopecia areata. Abstract SSS28.8. The 14th Congress of the European Academy of Dermatology and Venereology, London,UK. 12-15th October 2005. Journal of the European Academy of Dermatology and Venereology 2005;19(Suppl 2):38-9.
36. Vestey 1985 Vestey J P. Topical minoxidil in alopecia areata:a double blind trial. Abstract. British Journal of Dermatology 1985;113(Suppl 29):35.
37. Vestey 1986 Vestey JP SJ. A trial of 1% minoxidil used topically for severe alopecia areata. Acta Dermato-Venereologica 1986;66(2):179-80.
38. CSG 15 Amladi S. A randomised active-controlled double-blind study of topical tacrolimus 0.1% ointment versus conventional treatment with mid-potency topical steroid ointment in alopecia areata. Trial start date 01/12/2003. CSG15.
39. CSG 30 Sharifi M. Effect of laser examination in alopecia areata. Trial start date 01/01/2003. CSG30.
40. NCT00167102 NCT00167102. Alefacept in patients with severe scalp alopecia areata. www.clinicaltrials.gov.
41. NCT00187577 NCT00187577. Efficacy study of latanoprost and bimatoprost solutions in promoting eyelash growth in patients with alopecia areata. www.clinicaltrials.gov.
42. Colombe 1999 Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. Journal of Investigative Dermatology. Symposium proceedings 1999;4(3):216-9.
43. Egger 2003 Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews?. Health Technology Assessment 2003;7:1-76.
44. Epstein 2001 Epstein E. Evidence-based treatment of alopecia areata.[comment]. Journal of the American Academy of Dermatology 2001 Oct;45(4):640-2.
45. Firooz 2005 Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients with alopecia areata about their disease. BMC Dermatology 2005;5(1):1-5.
46. Garcia Bartels 2006 Garcia Bartels N, Lee HH, Worm M, Burmester GR, Sterry W, Blume-Peytavi U. Development of alopecia areata universalis in a patient receiving adalimumab. Archives of Dermatology 2006;142:1654-5.
47. Glasziou 2007 Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal fromnoise.[see comment]. BMJ 2007 Feb 17;334(7589):349-51.
48. Green 2000 Green J, Sinclair R. Genetics of Alopecia Areata. Australian Journal of Dermatology 2000;41:213-8.
49. Hay 1998 Hay IC, Jamieson M, Ormerod AD. Randomized trial of aromatherapy. Successful treatment for alopecia areata. Archives of Dermatology 1998;134(11):1349-52.
50. Higgins 2005 Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons Ltd, 2005.
51. Hutchinson 1987 Hutchinson E. Therapy versus placebo for alopecia areata. Journal of the American Academy of Dermatology 1987 Sep;17(3):516-7.
52. Juni 2001 Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
53. MacDonald Hull 2003 MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG, British Association of Dermatologists. Guidelines for the management of alopecia areata.[see comment]. British Journal of Dermatology 2003 Oct;149(4):692-9.
54. Madani 2000 Madani S, Shapiro J. Alopecia areata update. Journal of the American Academy of Dermatology 2000;42(4):549-66.
55. McMichael 1998 McMichael A. Impact of hair disorders and pigment disorders on quality of life. In: RajagopalanR, SherertzE, AndersonR editor(s). Care Management of Skin Diseases, Life Quality and Economic Impact. New York: Marcel Dekker, 1998:207-23.
56. McMichael 2003 McMichael AJ. The new biologics in psoriasis: possible treatments for alopecia areata. Journal of Investigative Dermatology Symposium Proceedings. 2003; Vol. 8:217-8.
57. Monk 1989 Monk B. Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clinical & Experimental Dermatology 1989 Mar;14(2):154-7.
58. Muller 1963 Muller SA, Winkelmann RK. Alopecia areata: an evaluation of 736 patients. Archives of Dermatology 1963;88:290- 297.
59. Olsen 2004 Olsen E A, et al.Alpecia areata investigational assessment guidelines -Part II. Journal of the American Academy of Dermatology 2004;51:440-7.
60. Price 2003 Price VH. Therapy of alopecia areata: on the cusp and in the future. Journal of Investigative Dermatology Symposium Proceedings. 2003; Vol. 8:207-11.
61. Safavi 1995 Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted county, Minnesota, 1975 through 1989. Mayo Clinic Proceedings 1995;70(7):628-33.
62. Schmidt 2001 Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. British Journal of Dermatology 2001 May;144(5):1038-43.
63. Sinclair 1999 Sinclair RD. Alopecia areata. In: SinclairR, BanfieldC, DawberR editor(s). Handbook of diseases of the hair and scalp. London: Blackwell Science, 1999:75-84.
64. Tosti 2006 Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G. Alopecia areata during treatment with biologic agents. Archives of Dermatology 2006;142:1653-4.
65. van der Steen 1991 van der Steen PH. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. Journal of the American Academy of Dermatology 1991;24(2):227-30.